News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Kellie Rademacher

Advertisement

Articles by Kellie Rademacher

The AI Boom in Healthcare: How Manufacturers Can Prepare

ByKellie Rademacher
December 12th 2019

Kellie Rademacher identifies some of the key questions to consider when choosing an AI partner.

Payers PQ.png

The Total Care Package

ByJeremy Schafer,Kellie Rademacher
May 5th 2018

Charting the course that has led to payer vertical integration and what it may mean for pharma manufacturers.

Advertisement

Latest Updated Articles

  • Payers PQ.png
    The Total Care Package

    Published: May 5th 2018 | Updated:

  • The AI Boom in Healthcare: How Manufacturers Can Prepare
    The AI Boom in Healthcare: How Manufacturers Can Prepare

    Published: December 12th 2019 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release

2

FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma

3

Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience

4

Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits

5

The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us